Wedbush has a “Outperform” rating and a $40.00 price target on the stock. The consensus estimate for AnaptysBio’s current full-year earnings is ($6.08) per share. Get AnaptysBio alerts: ...

Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will ...

Wedbush highlights Palantir and Salesforce as top AI investments, predicting rapid enterprise adoption and major capital ...

According to 4.5-star Wedbush Securities analyst Dan Ives, the broader software industry is now set to benefit from the exploding use cases of ...

Looking ahead, IDC estimates AI platform sales will increase at 40% annually to reach $153 billion by 2028. Palantir ...

Wedbush said Palantir Technologies (PLTR) and Salesforce (CRM) remain the two best software plays on the AI Revolution for 2025.

Denny's (DENN) sees a rally after Wedbush upgrades stock on growth potential and expected earnings beat in Q4.

Roblox stock is down Thursday after the gaming company came up short on key metrics for its fourth quarter. Here's what you ...

Wedbush analyst Nick Setyan upgraded Denny’s (DENN) to Outperform from Neutral with a price target of $10, up from $6. First, the firm believes ...

Elon Musk is not interested in buying video-sharing platform TikTok, the CEO of Tesla and SpaceX said during a virtual ...